EE171 Cost Offset and Budget Impact of Skytrofa for the Treatment of Pediatric Growth Hormone Deficiency: A US Payer’s Perspective
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.440
https://www.valueinhealthjournal.com/article/S1098-3015(23)03570-2/fulltext
Title :
EE171 Cost Offset and Budget Impact of Skytrofa for the Treatment of Pediatric Growth Hormone Deficiency: A US Payer’s Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03570-2&doi=10.1016/j.jval.2023.09.440
First page :
Section Title :
Open access? :
No
Section Order :
12466